Vanatex HCT

Medicinal product

(Invented) name

Vanatex HCT

Active substance (s)

Valsartanas/Hidrochlorotiazidas

Strength

160 mg/12,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DA03, Valsartan and diuretics

Marketing authorisation holder

Zakłady Farmaceutyczne POLPHARMA S.A., Lenkija

Date of authorisation

2011-06-06

Date of renewal

2016-02-15

Documents

2504 Vanatex HCT RPP 2024 12 19.docx

2504 Pakuotės lapelis 2024 12 19.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LT/H/0151/002

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Valsartanas	160 mg
Hidrochlorotiazidas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47126	60939	1060939	lizdinė plokštelė	N14		Receptinis	LT/1/11/2504/003	Netiekiama	-	-	No	-	-
34048	36406	1036406	lizdinė plokštelė	N28		Receptinis	LT/1/11/2504/004	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2016-02-15	Perregistruotas
2011-06-06	Registruotas